Hyphens Pharma International Limited
Research Hyphens Pharma International Limited (1J5.SI) on Bullrun: market cap SGD 112.75M, P/E 12.3, dividend yield 4.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1J5.SI
- ExchangeSGX
- CountrySingapore
- SectorHealthcare
- IndustryMedical Distribution
- CurrencySGD
- Market capSGD 112.75M
- P/E12.3
- Dividend yield4.1%
- Financial periodFY2025
- RevenueSGD 177.37M
- Revenue growth-9.2%
- Net incomeSGD 5.84M
- Free cash flowSGD 17.49M
- Gross margin40.7%
Valuation Snapshot
latest market cap is SGD 112.75M; P/E is 12.3; dividend yield is 4.1%.
Peer valuation comparison
Latest P/E is 12.33x versus a Healthcare sector median of 21.74x (43.3% below).
Latest dividend yield is 4.05% versus a Healthcare sector median of 2.4% (68.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SGD 177.37M | SGD 5.84M | SGD 17.49M | 40.7% | 0.02 | SGD 26.83M | SGD 9.43M | SGD 70.06M |
| FY2024 | SGD 195.42M | SGD 10.19M | -SGD 3.12M | 35.6% | 0.03 | SGD 23.42M | SGD 14.11M | SGD 70.90M |
| FY2023 | SGD 170.60M | SGD 8.57M | SGD 4.45M | 36.3% | 0.03 | SGD 23.37M | SGD 6.82M | SGD 62.99M |
| FY2022 | SGD 162.32M | SGD 11.35M | SGD 15.56M | 38.7% | 0.04 | SGD 36.48M | SGD 5.67M | SGD 69.03M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | SGD 112.75M | 12.3 | 4.1% | 0.02 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.02 SGD, yield 4.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.02 SGD |
| FY2024 | 0.01 SGD |
| FY2023 | 0.05 SGD |
| FY2022 | 0.01 SGD |
About Hyphens Pharma International Limited
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Pharmaceutical and Medical Aesthetics; Proprietary Brands; and Digital Platform and E-Pharmacy segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hyphens Pharma International Limited's market cap?
Hyphens Pharma International Limited's market capitalization is SGD 112.75M.
What is Hyphens Pharma International Limited's P/E ratio?
Hyphens Pharma International Limited's price-to-earnings (P/E) ratio is 12.3.
Does Hyphens Pharma International Limited pay a dividend?
Hyphens Pharma International Limited has a dividend yield of 4.1%.
What does Hyphens Pharma International Limited do?
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Pharmaceutical and Medical Aesthetics; Proprietary Brands; and Digital Platform and E-Pharmacy segments. The Pharmaceutical and Medical Aesthetics segment markets and sells a range of pharmaceutical and medical aesthetics products, including the Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products in ASEAN countries.